Premium
HRT should be considered as first line therapy for perimenopausal depression: AGAINST: More clinical trials are needed
Author(s) -
Craig Michael C
Publication year - 2016
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.13921
Subject(s) - premenstrual dysphoric disorder , depression (economics) , menopause , mood , estrogen , medicine , psychiatry , major depressive disorder , hormone replacement therapy (female to male) , observational study , mood disorders , psychology , irritability , hormone , menstrual cycle , testosterone (patch) , anxiety , economics , macroeconomics